Citadel Advisors »

Kiora Pharmaceuticals shares owned by Citadel Advisors

Quarter-by-quarter ownership of Kiora Pharmaceuticals (KPRX) shares owned by Citadel Advisors from 13F filings

Historical chart of Citadel Advisors investment in Kiora Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Kiora Pharmaceuticals held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Kiora Pharmaceuticals by Citadel Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $49k 93k 0.53
2023-03-31 $47k 14k 3.34

More positions owned by Citadel Advisors

Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
NVIDIA Corporation Call Option (NVDA)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Microsoft Corporation Call Option (MSFT)
Meta Platforms Cl A Call Option (META)
Tesla Motors Call Option (TSLA)
Apple Call Option (AAPL)
Amazon Call Option (AMZN)
Advanced Micro Devices Call Option (AMD)
Broadcom Call Option (AVGO)
Ishares Tr Iboxx Hi Yd Etf Call Option (HYG)
Alphabet Cap Stk Cl C Call Option (GOOG)
Netflix Call Option (NFLX)
Alphabet Cap Stk Cl A Call Option (GOOGL)

View all positions for Citadel Advisors

Top funds holding Kiora Pharmaceuticals

Alyeska Investment Group
Rosalind Advisors
AIGH Capital Management
Nantahala Capital Management
Velan Capital Investment Management
ADAR1 Capital Management
Captrust Financial Advisors
Geode Capital Management
Virtu Financial
XTX Topco
Vanguard Group
Hrt Financial
BlackRock
Two Sigma Investments
Tower Research Capital

View all funds holding Kiora Pharmaceuticals